![Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis - ScienceDirect Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S154235651930607X-gr1.jpg)
Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis - ScienceDirect
![Figure 43, Forest plot for gastrointestinal bleeding—apixaban, rivaroxaban, or edoxaban (treatment) versus dabigatran (control) (observational) - Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update - NCBI Bookshelf Figure 43, Forest plot for gastrointestinal bleeding—apixaban, rivaroxaban, or edoxaban (treatment) versus dabigatran (control) (observational) - Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK534143/bin/ch4f42.jpg)
Figure 43, Forest plot for gastrointestinal bleeding—apixaban, rivaroxaban, or edoxaban (treatment) versus dabigatran (control) (observational) - Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update - NCBI Bookshelf
![Frontiers | Effectiveness and Safety of Under or Over-dosing of Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-analysis of 148909 Patients From 10 Real-World Studies | Pharmacology Frontiers | Effectiveness and Safety of Under or Over-dosing of Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-analysis of 148909 Patients From 10 Real-World Studies | Pharmacology](https://www.frontiersin.org/files/MyHome%20Article%20Library/645479/645479_Thumb_400.jpg)
Frontiers | Effectiveness and Safety of Under or Over-dosing of Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-analysis of 148909 Patients From 10 Real-World Studies | Pharmacology
![New predictive model for acute gastrointestinal bleeding in patients taking oral anticoagulants: A cohort study - Shimomura - 2018 - Journal of Gastroenterology and Hepatology - Wiley Online Library New predictive model for acute gastrointestinal bleeding in patients taking oral anticoagulants: A cohort study - Shimomura - 2018 - Journal of Gastroenterology and Hepatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/6585702f-f1a4-41c9-9d8e-c60e200f92cd/jgh13830-fig-0001-m.jpg)
New predictive model for acute gastrointestinal bleeding in patients taking oral anticoagulants: A cohort study - Shimomura - 2018 - Journal of Gastroenterology and Hepatology - Wiley Online Library
![Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis](https://f6publishing.blob.core.windows.net/3c813342-91bc-4ec6-8a77-037322dff3a1/WJC-13-82-g003.png)
Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis
![Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin | Stroke Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin | Stroke](https://www.ahajournals.org/cms/asset/4f50784c-7535-463f-9a17-d71045b69add/3291fig02.jpeg)
Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin | Stroke
![Bleeding outcomes. A) Major bleeding: All four new oral anticoagulants... | Download Scientific Diagram Bleeding outcomes. A) Major bleeding: All four new oral anticoagulants... | Download Scientific Diagram](https://www.researchgate.net/profile/Mandy-Lauw/publication/260271110/figure/fig1/AS:341616649883650@1458459164486/Bleeding-outcomes-A-Major-bleeding-All-four-new-oral-anticoagulants-NOACs-were-at.png)
Bleeding outcomes. A) Major bleeding: All four new oral anticoagulants... | Download Scientific Diagram
![Libraries Back Pharmacist Pharmacist CE LibraryMTM Certificate ProgramVeterinary Pharmacy Certificate ProgramLaw Library for PharmacistsMedication Safety for Pharmacists Pharmacy Technician Pharmacy Technician LibraryMTM Certificate Program ... Libraries Back Pharmacist Pharmacist CE LibraryMTM Certificate ProgramVeterinary Pharmacy Certificate ProgramLaw Library for PharmacistsMedication Safety for Pharmacists Pharmacy Technician Pharmacy Technician LibraryMTM Certificate Program ...](https://www.powerpak.com/courses/116986/fig1.gif)
Libraries Back Pharmacist Pharmacist CE LibraryMTM Certificate ProgramVeterinary Pharmacy Certificate ProgramLaw Library for PharmacistsMedication Safety for Pharmacists Pharmacy Technician Pharmacy Technician LibraryMTM Certificate Program ...
![History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial - ScienceDirect History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002870316000168-gr1.jpg)
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial - ScienceDirect
![Better clinical outcomes with DOACs vs. warfarin in patients with NVAF and low body weight - PACE-CME Better clinical outcomes with DOACs vs. warfarin in patients with NVAF and low body weight - PACE-CME](https://pace-cme.org/2019/03/05/better-clinical-outcomes-with-doacs-vs-warfarin-in-patients-with-nvaf-and-low-body-weight/images/Better-clinical-outcomes-with-DOACs-vs-warfarin-in-patients-with-NVAF-and-low-body-weight-2x.png)
Better clinical outcomes with DOACs vs. warfarin in patients with NVAF and low body weight - PACE-CME
![Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis](https://f6publishing.blob.core.windows.net/3c813342-91bc-4ec6-8a77-037322dff3a1/WJC-13-82-g004.png)
Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis
![Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation | Scientific Reports Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-43224-4/MediaObjects/41598_2019_43224_Fig1_HTML.png)
Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation | Scientific Reports
![Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study | The BMJ Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study | The BMJ](https://www.bmj.com/content/bmj/350/bmj.h1857/F2.large.jpg)